Tami McMullin, PhD
Dr. Tami McMullin has over 13 years of multi-disciplinary experience providing scientific and risk communication solutions to complex health risk challenges in the private and public sectors. Her areas of expertise include public health and regulatory toxicology and risk assessment, product safety assessments, pharmacokinetics, in silico toxicology, neuroendocrine toxicology, biomonitoring, and environmental risk assessment.
For over a decade, Dr. McMullin worked as a regulatory and consulting toxicologist in the chemical industry, where she provided consultation on the safety of a diverse portfolio of industrial and agricultural chemicals, personal care products and medical devices.
During her tenure as the state toxicologist for Colorado, Dr. McMullin led teams to evaluate health risks related to chemical exposures for a variety of issues, such as superfund waste sites, brownfields, and oil and gas exploration and development.
More recently, Dr. McMullin’s practice has focused on assessing health risks related to community-based exposure in the oil and gas sector. She has served as a national expert to companies, governments and communities that seek to address public health concerns related to oil and gas exploration and development.
Dr. McMullin also specializes in communicating technical health risk information to multiple stakeholders, including citizen community groups, industry, and local public health agencies and policymakers. She has taught graduate level risk assessment courses at the Colorado School of Mines and is a peer reviewer of many technical publications
- 1999 - 2005: Ph.D., Toxicology - Colorado State University
- 1992 - 1997: B.S. Biology - University of California
Registrations & Certifications
- OSHA 40-Hour HAZWOPER
- 8-Hour Annual HAZWOPER Supervisor
- TERA Certified inhalation dosimetry concepts and methods for risk assessment
- Member, Society of Risk Analysis
- Member, Society of Toxicology
- Member, AIHA – Rocky Mountain Region
- Exposures and health risks from volatile organic compounds in communities located near oil and gas exploration and production activities in Colorado
- Development of an integrated multi-species and multi-dose route PBPK model for volatile methyl siloxanes - D4 and D5
- Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water
- The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events
- Safe human exposure limits for airborne linear siloxanes during spaceflight
- Dynamic changes in lipids and proteins of maternal, fetal, and pup blood and milk during perinatal development in CD and Wistar rats
- Oral absorption and oxidative metabolism of atrazine in rats evaluated by physiological modeling approaches
- Estimating constants for metabolism of atrazine in freshly isolated rat hepatocytes by kinetic modeling
- Evidence that atrazine and diaminochlorotriazine inhibit the estrogen/progesterone induced surge of luteinizing hormone in female Sprague-Dawley rats without changing estrogen receptor action
- A Systematic Review of Epidemiologic Literature Assessing Health Outcomes in Populations Living near Oil and Natural Gas Operations: Study Quality and Future Recommendations
- Bamber, A., Hasanali S.H., Nair, A.S., Watkins, S.M., Vigil, D.I., Van Dyke, M., McMullin, T.S., Richardson, K. (2019). A systematic review of the epidemiologic literature assessing health outcomes in populations living near oil and natural gas operations: study quality and future recommendations. Int J Environ Res Public Health. 2019 Jun 15;16(12). pii: E2123.